rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    MGNX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      MacroGenics (MGNX) Reports Q3 Loss, Lags Revenue Estimates
      Nov 12Yahoo FinanceMGNX
      MacroGenics: Q3 Earnings Snapshot
      Nov 12Yahoo FinanceMGNX
      MacroGenics at Stifel 2026 Healthcare Conference: leaner pipeline, bigger bets
      Nov 11Investing.comMGNXSF
      MacroGenics Inc earnings missed, revenue fell short of estimates
      Nov 5Investing.comMGNX
      MacroGenics Announces Appointments of Emil Kuriakose, M.D., and Michael Vasconcelles, M.D., to Board of Directors
      Nov 3Yahoo FinanceMGNX
      MacroGenics reports interim results for lorigerlimab in cancer trial
      Oct 26Investing.comMGNX
      MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN
      Oct 23Yahoo FinanceMGNX
      MacroGenics doses first patient in MGC030 cancer trial
      Oct 15Investing.comMGNX
      Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?
      Oct 9Yahoo FinanceMGNX
      Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?
      Sep 23Yahoo FinanceCCCCMGNX
      MacroGenics at H.C. Wainwright conference: leaner model, rich pipeline
      Sep 16Investing.comMGNX
      MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

      ROCKVILLE, MD, Sept. 09, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will present at the H.C. Wainwright 28th Annual Global Investment Conference on Wednesday, September 16, 2026, at 9:30 a.m. ET. A webcast of the presentation may be accessed under "Events & Presentations" in the Investor Relations

      Sep 9Yahoo FinanceMGNX
      MacroGenics: Inexpensive ADC/TCE Biotech With Multiple Catalysts Ahead (NASDAQ:MGNX)
      Sep 9Seeking AlphaMGNX

      This is the newest page. Registered accounts read further back.